Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $1B. The median disclosed raise is $69M, and the largest is Ronovo Surgical at $211M, ahead of Cardior Pharmaceuticals ($94M) and Rgenta Therapeutics ($90M).

The names that recur most often on these co-invested cap tables are Boehringer Ingelheim Venture Fund (14 companies), AMR Action Fund (4 companies), Vivo Capital (2 companies), Matrix Partners China (2 companies), BioMedPartners (2 companies), Delos Capital (2 companies). By latest disclosed round, the market skews Series B (7), Series A (5), Series D (1), Series C (1).

• Companies tracked: 14
• Disclosed funding total: $1B across 14 companies
• Median disclosed raise: $69M
• Largest raise: Ronovo Surgical — $211M
• Stage mix: Series B 7 · Series A 5 · Series D 1 · Series C 1
• Most recent dated round: 2025-09-05

Best funded Boehringer Ingelheim Venture Fund companies

1. Ronovo Surgical — $211M (latest: Series D)
2. Cardior Pharmaceuticals — $94M (latest: Series B)
3. Rgenta Therapeutics — $90M (latest: Series A)
4. Elion Therapeutics — $81M (latest: Series B)
5. NBE-Therapeutics — $79M (latest: Series A)
6. OncoMyx Therapeutics — $75M (latest: Series B)
7. Nuevocor — $69M (latest: Series B)
8. Brainomix — $68M (latest: Series C)
9. Actym Therapeutics, Inc. — $60M (latest: Series A)
10. Aignostics — $54M (latest: Series B)
11. Otto — $48M (latest: Series B)
12. Centauri Therapeutics — $38M (latest: Series A)
13. DiogenX — $35M (latest: Series A)
14. Hookipa Pharma — $30M (latest: Series B)

Boehringer Ingelheim Venture Fund — related firms and companies (56)

• Ronovo Surgical
• Cardior Pharmaceuticals
• Rgenta Therapeutics
• Elion Therapeutics
• NBE-Therapeutics
• OncoMyx Therapeutics
• Nuevocor
• Brainomix
• Investors like Wellington Management
• Investors like Ribbit Capital
• Investors like Polaris Partners
• Investors like 137 Ventures
• Investors like Venrock
• Investors like GIC
• Investors like Betaworks
• Investors like Balderton Capital
• Centauri Therapeutics
• Investors like Boehringer Ingelheim Venture Fund
• Investors like Benchmark
• Investors like Canapi Ventures
• Firms like GV
• Investors like Thirdbase Capital
• Investors like International Finance Corporation
• Investors like Casdin Capital
• Investors like Sutter Hill Ventures
• Investors like Bessemer Venture Partners
• Investors like Digital Currency Group
• Investors like Insight Partners
• Otto
• Boehringer Ingelheim Venture Fund portfolio companies 2026
• Investors like Service Provider Capital
• Investors like Sequoia Capital
• Investors like Torch Capital
• Investors like Kleiner Perkins
• Investors like Great Oaks Venture Capital
• Investors like Alumni Ventures
• Investors like Contour Venture Partners
• Investors like True Ventures
• Investors like Next47
• Investors like 500 Global
• Aignostics
• Hookipa Pharma
• Investors like DCM Ventures
• Investors like Battery Ventures
• Investors like GSR Ventures
• Investors like Menlo Ventures
• Investors like Soma Capital
• Investors like Correlation Ventures
• Investors like Shasta Ventures
• Investors like SOSV
• Investors like Maven Ventures
• Investors like Headline
• Actym Therapeutics, Inc.
• DiogenX
• Companies backed by Boehringer Ingelheim Venture Fund
• Investors like Initialized Capital

Boehringer Ingelheim Venture Fund alternatives · All research reports